6512 A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel

✍ Scribed by Cereda, S.; Reni, M.; Rognone, A.; Ghidini, M.; Rezzonico, S.; Passoni, P.; Mazza, E.; Belli, C.; Zerbi, A.; Villa, E.

• Book ID: 123207421
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 48 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71234-0